- cafead Aug 02, 2016 at 12:01: PM
Much has been said about Martin Shkreli in recent months. In particular, a lot of discussion has centered around his raising the price of the AIDS drug Daraprim at Turing Pharmaceuticals from $13.50 to $750 a tablet (approximately 5400%). Was he wrong to do so?